Effect of Urgent Clinician Notification of Low Hemoglobin Values (Evidence-Based Laboratory Medicine and Test Utilization) Effect of Urgent Clinician Notification of Low Hemoglobin Values (Evidence-Based Laboratory Medicine and Test Utilization)

Effect of Urgent Clinician Notification of Low Hemoglobin Values (Evidence-Based Laboratory Medicine and Test Utilization‪)‬

Clinical Chemistry 2001, Jan, 47, 1

    • 2,99 €
    • 2,99 €

Publisher Description

Red blood cell transfusions generally are recommended in hospitalized patients if the hemoglobin is 60 g/L (1, 2). Delay in appropriate use of red cell transfusion might put the patient at risk for hypoxic complications. Although the risk of acute events attributable to anemia probably occurs only with a hemoglobin concentration 50 g/L (2, 3), patients with ischemic heart disease might be at risk with higher values. Because the clinical signs of anemia are unreliable (4, 5), contacting the physician immediately when the blood count is unexpectedly low could be prudent. Immediate physician notification of a low hemoglobin obtained during an office visit, however, might lead to adverse consequences. Inappropriate notification squanders human resources and penalizes the physician with an untimely information overload (6, 7). A telephone call, in itself, might suggest the need for immediate attention, leading to unwarranted referrals to the emergency room (ER), inconvenience and anxiety for patient and family, and even unnecessary blood transfusions (2, 8). We are unaware of any outcome studies that demonstrate either the benefits or risks of this practice. Materials and Methods

GENRE
Science & Nature
RELEASED
2001
1 January
LANGUAGE
EN
English
LENGTH
12
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SIZE
193.6
KB

More Books by Clinical Chemistry

D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004
Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs) Congenital Analbuminemia Attributable to Compound Heterozygosity for Novel Mutations in the Albumin Gene (Technical Briefs)
2005
Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs) Measurement of Pro-C-Type Natriuretic Peptide in Plasma (Technical Briefs)
2005
Newborn Screening for Lysosomal Storage Disorders (Editorials) Newborn Screening for Lysosomal Storage Disorders (Editorials)
2005
Inadequate Attempts to Measure the Microheterogeneity of Transthyretin by Low-Resolution Mass Spectrometry (Letters) (Letter to the Editor) Inadequate Attempts to Measure the Microheterogeneity of Transthyretin by Low-Resolution Mass Spectrometry (Letters) (Letter to the Editor)
2005